John Chalmers AC's Publications

About John Chalmers AC's Publications

Senior Director, Professorial Unit, The George Institute (Australia)
  • Professor of Medicine, UNSW Sydney
  • Emeritus Professor of Medicine at Flinders University and at the University of Sydney
  • FAA,
  • FAHMS,
  • FRACP

  • Haematoma volume measurement techniques and their influence on outcome: INTERACT2

    Date published:

  • Low ambient temperature triggers intracerebral haemorrhage: The INTERACT2 study

    Date published:

  • Predicting the Effects of Blood Pressure-Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes Mellitus

    Hypertension Date published:

  • Older age is a strong predictor for poor outcome in intracerebral haemorrhage: the INTERACT2 study

    Age and Ageing Date published:

  • The speed of ultraearly hematoma growth in acute intracerebral hemorrhage

    Neurology Date published:

  • Ambient Temperature and Volume of Perihematomal Edema in Acute Intracerebral Haemorrhage: The INTERACT1 Study

    International Journal of Stroke Date published:

  • Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes

    New England Journal of Medicine Date published:

  • The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease

    International Journal of Cardiology Date published:

  • Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes

    Diabetologia Date published:

  • Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data

    The Lancet Date published:

  • Do Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial

    Diabetes Care Date published:

  • Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial

    Diabetes Care Date published:

  • Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality

    JAMA Date published:

  • GLP-1 receptor agonists in type 2 diabetes - NICE guidelines versus clinical practice

    The British Journal of Diabetes & Vascular Disease Date published:

  • Are the effects of telmisartan more marked in hypertensive patients?

    Journal of Hypertension Date published:

  • Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial

    Journal of Neurology, Neurosurgery & Psychiatry Date published: